Your browser doesn't support javascript.
loading
CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies.
Perez de Acha, Olivia; Reiman, Lauren; Jayabalan, David S; Walker, Zachary J; Bosma, Grace; Keller, Alana L; Parzych, Sarah E; Abbott, Diana; Idler, Beau M; Ribadeneyra, Drew; Niesvizky, Ruben; Forsberg, Peter A; Mark, Tomer M; Sherbenou, Daniel W.
  • Perez de Acha O; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Reiman L; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Jayabalan DS; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York-Presbyterian, New York City, NY.
  • Walker ZJ; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Bosma G; Department of Biostatistics and Informatics, Center for Innovative Design and Analysis, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Keller AL; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Parzych SE; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Abbott D; Department of Biostatistics and Informatics, Center for Innovative Design and Analysis, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Idler BM; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Ribadeneyra D; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York-Presbyterian, New York City, NY.
  • Niesvizky R; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York-Presbyterian, New York City, NY.
  • Forsberg PA; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Mark TM; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Sherbenou DW; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
Blood Adv ; 7(21): 6430-6440, 2023 11 14.
Article en En | MEDLINE | ID: mdl-37648670
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article